Annual D&A
$1.90 M
+$53.00 K+2.87%
December 31, 2023
Summary
- As of February 8, 2025, XLO annual depreciation & amortization is $1.90 million, with the most recent change of +$53.00 thousand (+2.87%) on December 31, 2023.
- During the last 3 years, XLO annual D&A has risen by +$835.00 thousand (+78.40%).
- XLO annual D&A is now at all-time high.
Performance
XLO Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$381.00 K
-$64.00 K-14.38%
September 30, 2024
Summary
- As of February 8, 2025, XLO quarterly depreciation & amortization is $381.00 thousand, with the most recent change of -$64.00 thousand (-14.38%) on September 30, 2024.
- Over the past year, XLO quarterly D&A has dropped by -$68.00 thousand (-15.14%).
- XLO quarterly D&A is now -23.65% below its all-time high of $499.00 thousand, reached on March 31, 2023.
Performance
XLO Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.72 M
-$79.00 K-4.40%
September 30, 2024
Summary
- As of February 8, 2025, XLO TTM depreciation & amortization is $1.72 million, with the most recent change of -$79.00 thousand (-4.40%) on September 30, 2024.
- Over the past year, XLO TTM D&A has dropped by -$182.00 thousand (-9.58%).
- XLO TTM D&A is now -12.03% below its all-time high of $1.95 million, reached on June 30, 2023.
Performance
XLO TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
XLO Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.9% | -15.1% | -9.6% |
| 3 y3 years | +78.4% | -15.1% | -9.6% |
| 5 y5 years | - | -15.1% | -9.6% |
XLO Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +26.8% | -23.6% | at low | -12.0% | +14.6% |
| 5 y | 5-year | at high | +691.7% | -23.6% | +8.9% | -12.0% | +390.9% |
| alltime | all time | at high | +691.7% | -23.6% | +8.9% | -12.0% | +390.9% |
Xilio Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $381.00 K(-14.4%) | $1.72 M(-4.4%) |
| Jun 2024 | - | $445.00 K(+0.5%) | $1.80 M(-2.5%) |
| Mar 2024 | - | $443.00 K(-1.3%) | $1.84 M(-2.9%) |
| Dec 2023 | $1.90 M(+2.9%) | $449.00 K(-2.4%) | $1.90 M(-2.1%) |
| Sep 2023 | - | $460.00 K(-6.5%) | $1.94 M(-0.7%) |
| Jun 2023 | - | $492.00 K(-1.4%) | $1.95 M(+2.5%) |
| Mar 2023 | - | $499.00 K(+2.0%) | $1.91 M(+3.2%) |
| Dec 2022 | $1.85 M | $489.00 K(+3.4%) | $1.85 M(+5.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | $473.00 K(+6.3%) | $1.75 M(+5.5%) |
| Jun 2022 | - | $445.00 K(+1.1%) | $1.66 M(+4.5%) |
| Mar 2022 | - | $440.00 K(+11.7%) | $1.59 M(+6.0%) |
| Dec 2021 | $1.50 M(+40.8%) | $394.00 K(+3.1%) | $1.50 M(+35.7%) |
| Sep 2021 | - | $382.00 K(+2.4%) | $1.10 M(+52.8%) |
| Jun 2021 | - | $373.00 K(+6.6%) | $723.00 K(+106.6%) |
| Mar 2021 | - | $350.00 K | $350.00 K |
| Dec 2020 | $1.06 M(+343.8%) | - | - |
| Dec 2019 | $240.00 K | - | - |
FAQ
- What is Xilio Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Xilio Therapeutics?
- What is Xilio Therapeutics annual D&A year-on-year change?
- What is Xilio Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Xilio Therapeutics?
- What is Xilio Therapeutics quarterly D&A year-on-year change?
- What is Xilio Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Xilio Therapeutics?
- What is Xilio Therapeutics TTM D&A year-on-year change?
What is Xilio Therapeutics annual depreciation & amortization?
The current annual D&A of XLO is $1.90 M
What is the all time high annual D&A for Xilio Therapeutics?
Xilio Therapeutics all-time high annual depreciation & amortization is $1.90 M
What is Xilio Therapeutics annual D&A year-on-year change?
Over the past year, XLO annual depreciation & amortization has changed by +$53.00 K (+2.87%)
What is Xilio Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of XLO is $381.00 K
What is the all time high quarterly D&A for Xilio Therapeutics?
Xilio Therapeutics all-time high quarterly depreciation & amortization is $499.00 K
What is Xilio Therapeutics quarterly D&A year-on-year change?
Over the past year, XLO quarterly depreciation & amortization has changed by -$68.00 K (-15.14%)
What is Xilio Therapeutics TTM depreciation & amortization?
The current TTM D&A of XLO is $1.72 M
What is the all time high TTM D&A for Xilio Therapeutics?
Xilio Therapeutics all-time high TTM depreciation & amortization is $1.95 M
What is Xilio Therapeutics TTM D&A year-on-year change?
Over the past year, XLO TTM depreciation & amortization has changed by -$182.00 K (-9.58%)